Becton, Dickinson and Co. | BDX - Net Income

Stock Price
207.87
Daily Change
1.37 0.66%
Monthly
4.48%
Yearly
-15.18%
Q1 Forecast
197.21

Becton, Dickinson and Co. reported $493M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Abbott USD 1.78B 132M Dec/2025
Agilent USD 434M 98M Sep/2025
Align Technology USD 56.75M 67.86M Sep/2025
Avanos Medical USD -1.4M 75.4M Sep/2025
Baxter International USD -46M 137M Sep/2025
Becton, Dickinson and Co. USD 493M 81M Sep/2025
Bio-Rad Laboratories USD 317.8M 253.8M Jun/2025
Boston Scientific USD 755M 42M Sep/2025
Cooper Companies USD 84.6M 13.7M Sep/2025
Danaher USD 1.2B 289M Dec/2025
Dentsply International USD -427M 382M Sep/2025
Dexcom USD 179.8M 74.4M Jun/2025
Edwards Lifesciences USD 291.1M 42.1M Sep/2025
Exact Sciences USD -19.59M 18.41M Sep/2025
Globus Medical USD 118.97M 83.88M Sep/2025
Hologic USD 179.1M 8.2M Dec/2025
Insulet USD 87.6M 65.1M Sep/2025
Integra LifeSciences USD -5.4M 478.67M Sep/2025
Intuitive Surgical USD 794.8M 90.4M Dec/2025
J&J USD 5.12B 36M Dec/2025
Masimo USD -100.4M 151.7M Sep/2025
Medtronic USD 1.37B 334M Sep/2025
Solventum Corp USD 1.27B 1.18B Sep/2025
Stryker USD 849M 10M Dec/2025
Tandem Diabetes Care USD -21.16M 31.24M Sep/2025
Teleflex USD -408.89M 531.47M Sep/2025
Terumo JPY 35.05B 6.79B Sep/2025
Thermo Fisher Scientific USD 1.96B 348M Dec/2025
Zimmer Biomet Holdings USD 230.9M 78.1M Sep/2025